Nine-year follow-up study of bromocriptine monotherapy for parkinson’s disease

European Neurology

Volumn 38, Issue 1, 1997, Pages 23-28

  Kowa, H ^a   Kanazawa, I ^b   Goto, I ^c   Kuno, S ^d   Mizuno, Y ^e   Ogawa, N ^f   Tashiro, K ^g   Yanagisawa, N ^h  

^a KITASATO UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d UTANO NATIONAL HOSPITAL   (Japan)

^e JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^g HOKKAIDO UNIVERSITY   (Japan)

^h SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bromocriptine; Dopamine receptor agonist; Long term treatment; Monotherapy

Indexed keywords

ANTIPARKINSON AGENT; BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGED; AKINESIA; CLINICAL ARTICLE; CONFERENCE PAPER; DETERIORATION; DISEASE SEVERITY; DYSKINESIA; FEMALE; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; MALE; NEUROPROTECTION; PARKINSON DISEASE; PRIORITY JOURNAL; RIGIDITY; STAGING; SYMPTOM; TREATMENT OUTCOME; TREMOR;

AGED; ANTIPARKINSON AGENTS; BROMOCRIPTINE; DYSKINESIA, DRUG-INDUCED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 0030750784     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000113439     Document Type: Article

References (6)

1. Nakanishi T, Iwata M, Goto I, Kanazawa I, Kowa H, Mannen T, Mizuno Y, Nishitani H, Ogawa N, Takahashi A, Tashiro K, Tohgi H, Yanagisawa N: Nationwide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients, Final report, Eur Neurol 1992:32(suppl 1):9-22.
2. Yanagisawa N, Kanazawa I, Goto I, Kowa H, Kuno S, Mizuno Y, Tashiro K, Ogawa N: Seven-year follow-up study of bromocriptine therapy for Parkinson’s disease, Eur Neurol 1994; 34(suppl 3):29-35.
3. Tashiro K, Goto I, Kanazawa I, Kowa H, Kuno S, Mizuno Y, Ogawa N, Yanagisawa N: Eight-year follow-up study of bromocriptine monotherapy for Parkinson's disease, Eur Neurol 1996;36(suppl 1):32-37.
4. Yoshikawa T, Minamiyama Y, Naito Y, Kon-do M: Antioxidanl properties of bromocriptine, a dopamine agonist, J Neurochem 1994; 62:1034-1038.
5. Ogawa N, Tanaka K, Asayama M, Kawai M, Masumizu T, Kohno M, Mori A: Bromocriptine protects mice against 6-hydrooxvdropam-ine and scavenges hydroxyl free radicals in vitro, Brain Res 1994;657(1-2):207-213.
6. Liu XH, Kato H, Chen T, Kato K, Itoyama Y: Bromocriptine protects against delayed neuronal death of hypocampal neurons following cerebral ischemia in the gerbil, J Neurol Sci 1995;129:9-14.